Prediction of weight loss and regain following dietary, lifestyle, and pharmacologic intervention

Clinical Pharmacology and Therapeutics

Volumn 91, Issue 6, 2012, Pages 1027-1034

  Napolitano, A ^a   Miller, S R ^a   Murgatroyd, P R ^a   Delafont, B ^a   Brooke, A ^a   Elkhawad, M ^b   Tan, C Y ^a   Virtue, S ^a   Vidal Puig, A ^a   Nunez, D J ^c  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SIBUTRAMINE;

ADULT; ARTICLE; BODY COMPOSITION; CONTROLLED STUDY; DIET THERAPY; FEMALE; HUMAN; INTERVENTION STUDY; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; OBESITY; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WEIGHT GAIN; WEIGHT REDUCTION;

ABSORPTIOMETRY, PHOTON; ADULT; APPETITE DEPRESSANTS; BODY COMPOSITION; BODY WEIGHT; CALORIMETRY, INDIRECT; CYCLOBUTANES; DIET, REDUCING; EATING; EXERCISE; FEMALE; FORECASTING; HUMANS; INSULIN RESISTANCE; LIFE STYLE; MAGNETIC RESONANCE IMAGING; MALE; OBESITY; RECURRENCE; SATIETY RESPONSE; WEIGHT GAIN; WEIGHT LOSS;

EID: 84863407828     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2011.333     Document Type: Article

References (24)

1. Wang, Z., Heshka, S., Zhang, K., Boozer, C.N. & Heymsfield, S.B. Resting energy expenditure: systematic organization and critique of prediction methods. Obes. Res. 9, 331-336 (2001). (Pubitemid 33603856)
2. Rikke, B.A., Battaglia, M.E., Allison, D.B. & Johnson, T.E. Murine weight loss exhibits significant genetic variation during dietary restriction. Physiol. Genomics 27, 122-130 (2006). (Pubitemid 46702027)
3. Heymsfield, S.B. et al. Why do obese patients not lose more weight when treated with low-calorie diets? A mechanistic perspective. Am. J. Clin. Nutr. 85, 346-354 (2007). (Pubitemid 46220933)
4. Rosenbaum, M. & Leibel, R.L. Adaptive thermogenesis in humans. Int. J. Obes. (Lond). 34 (suppl. 1), S47-S55 (2010).
5. Rosenbaum, M., Kissileff, H.R., Mayer, L.E., Hirsch, J. & Leibel, R.L. Energy intake in weight-reduced humans. Brain Res. 1350, 95-102 (2010).
6. Arvidsson, D., Slinde, F., Larsson, S. & Hulth, L. Energy cost of physical activities in children: validation of SenseWear Armband. Med. Sci. Sports Exerc. 39, 2076-2084 (2007). (Pubitemid 350073374)
7. Halford, J.C. et al. The effects of sibutramine on the microstructure of eating behaviour and energy expenditure in obese women. J. Psychopharmacol. (Oxford) 24, 99-109 (2010).
8. Hall, K.D. Predicting metabolic adaptation, body weight change, and energy intake in humans. Am. J. Physiol. Endocrinol. Metab. 298, E449-E466 (2010).
9. Finer, N., James, W.P., Kopelman, P.G., Lean, M.E. & Williams, G. One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor. Int. J. Obes. Relat. Metab. Disord. 24, 306-313 (2000). (Pubitemid 30137720)
10. Bray, G.A. et al. Sibutramine produces dose-related weight loss. Obes. Res. 7, 189-198 (1999). (Pubitemid 129710577)
11. Mutch, D.M. et al. Adipose gene expression prior to weight loss can differentiate and weakly predict dietary responders. PLoS ONE 2, e1344 (2007).
12. Newgard, C.B. et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 9, 311-326 (2009).
13. Laferre, B. et al. Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss. Sci. Transl. Med. 3, 80re2 (2011).
14. Finer, N. Sibutramine: its mode of action and efficacy. Int. J. Obes. Relat. Metab. Disord. 26 (suppl. 4), S29-S33 (2002). (Pubitemid 36071969)
15. Padwal, R.S. & Majumdar, S.R. Drug treatments for obesity: orlistat, sibutramine, and rimonabant. Lancet 369, 71-77 (2007). (Pubitemid 46027230)
16. Food and Agriculture Organization of the United Nations/World Health Organization/United Nations University. Report 724: Energy and Protein Requirements. Report of a Joint FAO/WHO/UNU Expert Consultation, 1985.
17. Napolitano, A. et al. Validation of a quantitative magnetic resonance method for measuring human body composition. Obesity (Silver Spring). 16, 191-198 (2008). (Pubitemid 351271971)
18. Swe Myint, K. et al. Quantitative magnetic resonance (QMR) for longitudinal evaluation of body composition changes with two dietary regimens. Obesity (Silver Spring). 18, 391-396 (2010).
19. Elia, M. & Livesey, G. Energy expenditure and fuel selection in biological systems: the theory and practice of calculations based on indirect calorimetry and tracer methods. In: Control of Eating, Energy Expenditure and the Bioenergetics of Obesity. Vol. 70, World Reviews in Nutrition and Dietetics (ed. Simopoulos, A.P.) 68-131 (Basel, Switzerland: Karger, 1992).
20. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F. & Turner, R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419 (1985). (Pubitemid 15018832)
21. Yeomans, M.R. Rating changes over the course of meals: what do they tell us about motivation to eat? Neurosci. Biobehav. Rev. 24, 249-259 (2000). (Pubitemid 30100449)
22. Flint, A., Raben, A., Blundell, J.E. & Astrup, A. Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int. J. Obes. Relat. Metab. Disord. 24, 38-48 (2000). (Pubitemid 30098877)
23. Barkeling, B., Elfhag, K., Rooth, P. & Rsner, S. Short-term effects of sibutramine (Reductil) on appetite and eating behaviour and the long-term therapeutic outcome. Int. J. Obes. Relat. Metab. Disord. 27, 693-700 (2003). (Pubitemid 36712953)
24. St-Onge, M., Mignault, D., Allison, D.B. & Rabasa-Lhoret, R. Evaluation of a portable device to measure daily energy expenditure in free-living adults. Am. J. Clin. Nutr. 85, 742-749 (2007). (Pubitemid 46393505)